Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hyundai Motor Company (005380) – Decision on Record Date for Year-End Cash/In-Kind Dividend

Posted on January 29, 2026July 23, 2026 By K-STOCK Editor No Comments on [Disclosure] Hyundai Motor Company (005380) – Decision on Record Date for Year-End Cash/In-Kind Dividend

Fact Source: Financial Supervisory Service DART / 2026-01-29

Disclosure Type: Decision on Closing of Shareholders’ Register (Record Date) for Cash/In-Kind Dividend

💡 3-Second Summary

Hyundai Motor Company resolved to set February 28, 2026, as the record date to determine shareholders eligible to receive the FY2025 year-end cash and in-kind dividend. The process will proceed without a register closure period.

📊 1. [Key Disclosure Details & Financial Figures Summary]

  • Dividend Category: Year-end dividend
  • Record Date: February 28, 2026
  • Share Register Closure Period: N/A (Eligible shareholders are determined solely by the record date without closing the share register)
  • Purpose: Determination of entitled shareholders for the FY2025 year-end dividend
  • Board Resolution Date: January 29, 2026 (All 7 independent directors attended)
  • Other Key Notes: All Audit Committee members consist of independent directors.

📈 2. [Expert Insight: What This Disclosure Means for Investors]

This filing is an administrative notice establishing the record date to identify shareholders entitled to receive the FY2025 year-end dividend.

Rather than closing the shareholder registry, the company designated February 28, 2026, as the official record date to confirm dividend eligibility for registered shareholders as of that date.

📝 Editor’s Comment (by K-STOCK Editor)

Hyundai Motor Company’s record date disclosure formally outlines the timeline for establishing shareholder eligibility for the FY2025 year-end distribution.

Investors should verify the record date (February 28, 2026) to ensure share ownership and settlement timelines align with dividend eligibility requirements.

📢 Disclaimer & Source Notice

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.

Contact Us: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Automotive

Post navigation

Previous Post: [Disclosure] Hyundai Motor Company (005380) – Decision on FY2025 Year-End Cash Dividend (KRW 2,500 per Common Share, Total Approx. KRW 660.16B)
Next Post: [Disclosure] Hyundai Motor Company (005380) – FY2025 Consolidated Revenue KRW 186.25T (+6.3%), Operating Profit KRW 11.47T (-19.5%)

Related Posts

[Disclosure] Celltrion (068270) – Decision on Capital Increase by Rights Offering (Major Management Matters of Subsidiary) / 2025-12-11 Disclosures
[Disclosure] Hana Micron (067310) – Change in Sales or Profit/Loss Structure by 30% or More / 2025-03-11 Disclosures
[Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-01-29 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-09-01 Semiconductors
[Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Sets Record Date for New Share Allocation in Rights Offering… Record Date Fixed for April 24, 2025 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme